Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
South Korea · Delayed Price · Currency is KRW 6,230.00
-170.00 (-2.66%)
May 15, 2026, 11:47 AM KST
Kyongbo Pharmaceutical Market Cap
Kyongbo Pharmaceutical has a market cap or net worth of 153 billion as of May 14, 2026. Its market cap has increased by 16.79% in one year.
Market Cap
153.00B
Enterprise Value
271.63B
Revenue
264.10B
Ranking
n/a
PE Ratio
839.32
Stock Price
6,230.00
Market Cap Chart
Since June 29, 2015, Kyongbo Pharmaceutical's market cap has decreased from 818.81B to 153.00B, a decrease of -81.31%. That is a compound annual growth rate of -14.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 151.81B | 10.05% |
| Dec 30, 2025 | 137.94B | -7.23% |
| Dec 30, 2024 | 148.70B | -25.86% |
| Dec 28, 2023 | 200.58B | -16.10% |
| Dec 29, 2022 | 239.07B | -6.98% |
| Dec 30, 2021 | 257.00B | -34.25% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| JW Lifescience | 195.11B |
| Jeil Pharmaceutical Co.,Ltd | 191.91B |
| Samil Pharmaceutical Co.,Ltd | 186.40B |
| Ilyang Pharmaceutical Co.,Ltd | 179.25B |
| Hana Pharm | 171.51B |
| SAMSUNG PHARM. Co., LTD. | 166.88B |
| Daihan Pharmaceutical | 165.52B |
| Dongwha Pharm.Co.,Ltd | 160.76B |